Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer (NCT06391008) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2024-04-30 |
Track Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.